Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Nov 19, 2025 · 10-Q · 50 days after period end · 0001683168-25-008543
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$165.36K | -$186.73K | -$333.25K | -$153.65K |
| EPS Diluted | -$0.02 | -$0.03 | -$0.05 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 19, 2025 · 50 d after period end
